Work With Your Doctor to Get Synagis (Palivizumab) Approved by Aetna CVS Health in Ohio: Complete Provider Collaboration Guide
Answer Box: Getting Synagis Approved in Ohio
Aetna CVS Health requires prior authorization for Synagis (palivizumab) via their precertification form, approving only high-risk infants when Beyfortus is contraindicated or unavailable. Your pediatrician must document specific criteria (prematurity <29 weeks GA, chronic lung disease, or hemodynamically significant heart disease) and submit within 30-45 days of RSV season start. First step today: Schedule an appointment with your child's specialist to gather birth records, NICU discharge summaries, and current medical status for the prior authorization packet.
Table of Contents
- Set Your Goal: Understanding Aetna's Requirements
- Prepare for Your Provider Visit
- Build Your Evidence Kit
- Medical Necessity Letter Structure
- Support Your Provider's Peer-to-Peer Review
- Document Your Visit
- Follow Up Respectfully
- Appeals Process in Ohio
- Frequently Asked Questions
Set Your Goal: Understanding Aetna's Requirements
Before your appointment, understand exactly what Aetna CVS Health needs to approve Synagis (palivizumab) for your high-risk infant. This partnership approach with your provider increases approval rates significantly.
Coverage Requirements at a Glance
| Requirement | What It Means | Where to Find It | Source |
|---|---|---|---|
| Prior Authorization | Must be approved before dispensing | Aetna Precertification List | Aetna |
| High-Risk Criteria | Specific medical conditions only | Clinical Policy Bulletin #0318 | Aetna |
| Beyfortus Justification | Must prove Beyfortus won't work | Medical records showing contraindication | Provider |
| Specialist Documentation | Cardiology/pulmonology notes required | Within 6 months of request | Provider |
| Season Timing | October-March typically in Ohio | Local RSV surveillance data | CDC/ODH |
Your role: Gather all medical records and coordinate between specialists. Provider's role: Complete the precertification form and submit clinical justification.
Note: Synagis will be discontinued December 31, 2025, making the 2025-2026 season potentially the final one available.
Prepare for Your Provider Visit
Success starts with thorough preparation. Your pediatrician or specialist needs comprehensive documentation to build a strong prior authorization case.
Essential Information to Compile
Birth and NICU History:
- Original birth certificate showing gestational age
- NICU discharge summary with oxygen requirements
- Any respiratory support details (ventilator days, CPAP duration)
- Birth weight and current growth measurements
Current Medical Status:
- Recent specialist visits (cardiology, pulmonology)
- Current medications, especially respiratory treatments
- Any hospitalizations since birth
- Daycare attendance or school-age siblings (risk factors)
Previous RSV Seasons:
- Prior Synagis doses received (dates, locations)
- Any RSV infections or hospitalizations
- Adverse reactions to previous immunizations
Questions to Ask Your Provider
- "Does my child meet Aetna's specific high-risk criteria?"
- "Why won't Beyfortus work for my child's situation?"
- "What additional specialist documentation do we need?"
- "Can you submit the prior authorization today?"
Build Your Evidence Kit
Work with your provider to assemble compelling clinical evidence that aligns with Aetna's Clinical Policy Bulletin #0318.
Required Clinical Documentation
For Prematurity (<29 weeks GA, <12 months old):
- Birth certificate or hospital records showing exact gestational age
- Current chronological age calculation
- Growth chart showing current weight for dosing
For Chronic Lung Disease (<24 months with ongoing support):
- Pulmonology notes documenting oxygen, bronchodilators, or steroids within 6 months
- Chest X-rays or pulmonary function tests
- NICU discharge summary showing >28 days oxygen requirement
For Congenital Heart Disease:
- Cardiology evaluation confirming hemodynamically significant disease
- Echocardiogram reports
- Surgical history or planned interventions
- Current heart failure medications
Supporting Guidelines and References
Your provider should reference these in the medical necessity letter:
- FDA prescribing information for Synagis
- American Academy of Pediatrics RSV prevention guidelines
- Relevant specialty society recommendations (American Heart Association, American Thoracic Society)
Medical Necessity Letter Structure
Partner with your provider to ensure their letter includes all required elements for Aetna approval.
Clinician Corner: Essential Letter Components
Opening Statement: "I am requesting prior authorization for Synagis (palivizumab) for [patient name], a [age]-month-old infant under my care who meets high-risk criteria for severe RSV disease."
Clinical Justification Checklist:
- Specific diagnosis with ICD-10 codes
- Exact gestational age and birth weight
- Current chronological age and weight
- Why Beyfortus is contraindicated/inappropriate
- Risk factors for severe RSV (siblings, daycare, smoke exposure)
- Treatment plan (15 mg/kg monthly x 5 doses)
- Consequences of denial (hospitalization risk)
Required Documentation Attachments:
- Birth certificate or NICU records
- Recent specialist consultation notes
- Growth chart with current measurements
- Insurance verification
Support Your Provider's Peer-to-Peer Review
If the initial prior authorization is denied, your provider may request a peer-to-peer review with Aetna's medical director.
How You Can Help
Prepare a Concise Case Summary:
- One-page timeline of your child's medical history
- List of current medications and specialists
- Documentation of any RSV-related hospitalizations in family
Offer Scheduling Flexibility:
- Provide multiple time windows when your provider is available
- Understand these calls often happen with short notice
- Be prepared to provide additional information quickly
Sample Provider Script for Peer-to-Peer
"I'm calling regarding [patient name, member ID] for Synagis prior authorization. This [age]-month-old infant born at [GA] weeks meets your policy criteria under [specific section]. Beyfortus is contraindicated due to [specific reason]. The child has [risk factors] and requires RSV prophylaxis to prevent hospitalization."
Document Your Visit
After each provider appointment, ensure proper documentation for potential appeals.
What to Save
From Each Visit:
- Copy of visit summary or clinical notes
- Any new test results or specialist referrals
- Updated medication lists
- Provider's assessment of RSV risk
Communication Records:
- Portal messages about prior authorization status
- Phone call logs with Aetna (date, representative name, outcome)
- Fax confirmations for submitted documents
Portal Communication Tips
When messaging your provider through the patient portal:
- Use clear subject lines: "Synagis PA - Additional Documentation Needed"
- Include specific requests: "Please fax growth chart to Aetna at 888-267-3277"
- Reference prior authorization number if available
Follow Up Respectfully
Maintain regular communication without overwhelming your provider's office.
Appropriate Follow-Up Timeline
Week 1: Confirm prior authorization was submitted Week 2: Check on initial review status Week 3: If no response, request status update Week 4: If denied, discuss appeal options immediately
How to Escalate Politely
"I understand you're busy, but with RSV season approaching, I'm concerned about timing for my child's Synagis approval. Could we schedule a brief call to discuss next steps?"
When to involve practice management:
- Repeated delays in submission
- Lack of response to urgent requests
- Need for expedited review due to RSV exposure
Appeals Process in Ohio
If Aetna denies coverage, Ohio provides robust appeal rights through the Ohio Department of Insurance.
Step-by-Step Appeals Timeline
| Level | Who Files | Deadline | Expected Timeline | Contact |
|---|---|---|---|---|
| Internal Appeal | Provider or patient | 180 days from denial | 30-45 days | Aetna Member Services |
| Expedited Internal | Provider (if urgent) | Immediately | 72 hours | 866-752-7021 |
| External Review | Patient to insurer | 180 days from final denial | 30 days standard, 72 hours expedited | Ohio Department of Insurance |
Required Documents for Appeals
For Internal Appeals:
- Original denial letter
- Updated medical records
- Additional specialist opinions
- Published guidelines supporting use
For External Review in Ohio:
- Final denial notice from Aetna
- All medical records
- Provider letter of medical necessity
- Any relevant clinical studies
Important: Ohio's external review is binding on insurers and costs nothing to patients. Contact ODI at 800-686-1526 if Aetna claims you're not eligible.
Frequently Asked Questions
How long does Aetna prior authorization take for Synagis in Ohio? Standard review takes 30-45 days, but expedited review (if RSV season has started) can be completed within 72 hours. Submit 2-4 weeks before anticipated need.
What if Synagis is not on Aetna's formulary? Synagis requires prior authorization regardless of formulary status. Your provider must demonstrate medical necessity and that Beyfortus is inappropriate for your child's condition.
Can I appeal if my child doesn't meet the exact criteria? Yes. If your child has other risk factors (neuromuscular disease, immunodeficiency), your provider can request an exception with supporting documentation from specialists.
Does step therapy apply to Synagis? Aetna typically requires trying Beyfortus first unless contraindicated. Your provider must document why Beyfortus won't work (allergy, prior failure, unavailability).
What happens if we miss the RSV season deadline? Late-season requests require documentation of local RSV activity (≥3% positivity for 2 weeks). Include CDC or Ohio Department of Health surveillance data.
How much does Synagis cost without insurance? Approximately $1,820 per 50mg vial as of 2025. Most high-risk infants need 5 monthly doses, making total cost around $9,000+ per season.
Getting Additional Help
If you're struggling with the prior authorization process, Counterforce Health specializes in turning insurance denials into targeted, evidence-backed appeals. Their platform helps patients and clinicians navigate complex payer requirements by analyzing denial letters and crafting point-by-point rebuttals aligned with each insurer's specific policies. For families facing Synagis denials, having expert support can make the difference between approval and another season of worry about RSV exposure.
For immediate assistance with Aetna appeals in Ohio, contact the Ohio Department of Insurance Consumer Services at 800-686-1526. They can help ensure your external review moves forward properly and answer questions about Ohio-specific appeal rights.
Sources & Further Reading
- Aetna Synagis Precertification Request Form
- Aetna Clinical Policy Bulletin #0318 - Synagis
- Ohio Department of Insurance External Review Process
- Aetna Precertification Lists
- CDC RSV Prevention Guidelines
Disclaimer: This guide provides general information about insurance coverage and is not medical advice. Always consult your healthcare provider for medical decisions and contact Aetna directly for current policy details. Coverage policies and procedures may change without notice.
Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.